Elli Kruithof
About
In The Last Decade
Elli Kruithof
39 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 72
- Rheumatology 2.1k
- Immunology 1.1k
- Hematology 874
- Molecular Biology 312
- Genetics 201
Countries citing papers authored by Elli Kruithof
This map shows the geographic impact of Elli Kruithof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elli Kruithof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elli Kruithof more than expected).
Fields of papers citing papers by Elli Kruithof
This network shows the impact of papers produced by Elli Kruithof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elli Kruithof. The network helps show where Elli Kruithof may publish in the future.
Co-authorship network of co-authors of Elli Kruithof
This figure shows the co-authorship network connecting the top 25 collaborators of Elli Kruithof. A scholar is included among the top collaborators of Elli Kruithof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elli Kruithof. Elli Kruithof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Anti-tumour necrosis factor alpha-induced apoptosis contributes to the induction of autoantibodies but not the downregulation of synovial inflammatory infiltration in spondyloarthritis | 1 |
| 2 | 9 | |
| 3 | Increased systemic and local expression of toll-like receptor 2 and 4 in spondyloarthropathy is downmodulated by tumour necrosis factor alpha blockade | 4 |
| 4 | IgM anti-dsDNA autoantibodies are the main antinuclear reactivity induced by infliximab but not etanercept treatment in vivo: Biological and clinical implications | 3 |
| 5 | Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase are pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity | 1 |
| 6 | Preliminary evidence for a retardation of structural damage in patients with ankylosing spondylitis continuously treated with infliximab for 4 years | 1 |
| 7 | Short and long term synovial immunumodulation by etanercept in spondyloarthropathy | 1 |
| 8 | Identification of synovial biomarkers of response to treatment in spondyloarthropathy | 1 |
| 9 | Impact of natural changes in disease activity on synovial histopathology in rheumatoid arthritis | 2 |
| 10 | 100 | |
| 11 | 122 | |
| 12 | 104 | |
| 13 | 116 | |
| 14 | 17 | |
| 15 | Rheumatoid factor and anti-citrullinated peptide antibodies in rheumatoid arthritis: Diagnostic value and association with radiological progression | 1 |
| 16 | 15 | |
| 17 | 159 | |
| 18 | 158 | |
| 19 | 225 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.